Eagle Wealth Strategies’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Eagle Wealth Strategies's BMY Position: Q2 2026 in Review
Eagle Wealth Strategies held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,953 shares worth $228K. The position accounts for 0.09% of the portfolio, ranked #104.
Eagle Wealth Strategies first reported a position in BMY in Q4 2023 and has held it in 8 quarters since. The position peaked at $240K in Q1 2026. 831 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Eagle Wealth Strategies held 3,953 shares of Bristol-Myers Squibb worth $228K as of Q2 2026.
- Eagle Wealth Strategies left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.09% of Eagle Wealth Strategies's portfolio in Q2 2026, its #104 holding.
- Eagle Wealth Strategies first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 8 quarters since.
- Eagle Wealth Strategies's Bristol-Myers Squibb position peaked at $240K in Q1 2026.
- 831 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Eagle Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.